Ma, Z. et al. 2018. Rh-endostatin Concomitant with Chemotherapy Versus Single Agent Chemotherapy for Treating Soft Tissue and Bone Sarcomas: A Systematic Review and Meta-Analysis. Journal of Pharmacy & Pharmaceutical Sciences. 21, 1 (Oct. 2018), 386–397. DOI:https://doi.org/10.18433/jpps30034.